Rous sarcoma virus genomic RNA dimerization capability in vitro is not a prerequisite for viral infectivity

Shuohui Liu, Rebecca Kaddis Maldonado, Tiffiny Rye-McCurdy, Christiana Binkley, Aissatou Bah, Eunice C. Chen, Breanna L. Rice, Leslie J. Parent, Karin Musier-Forsyth

Research output: Contribution to journalArticle

Abstract

Retroviruses package their full-length, dimeric genomic RNA (gRNA) via specific interactions between the Gag polyprotein and a “Ψ” packaging signal located in the gRNA 50-UTR. Rous sarcoma virus (RSV) gRNA has a contiguous, well-defined Ψ element, that directs the packaging of heterologous RNAs efficiently. The simplicity of RSV Ψ makes it an informative model to examine the mechanism of retroviral gRNA packaging, which is incompletely understood. Little is known about the structure of dimerization initiation sites or specific Gag interaction sites of RSV gRNA. Using selective 20-hydroxyl acylation analyzed by primer extension (SHAPE), we probed the secondary structure of the entire RSV 50-leader RNA for the first time. We identified a putative bipartite dimerization initiation signal (DIS), and mutation of both sites was required to significantly reduce dimerization in vitro. These mutations failed to reduce viral replication, suggesting that in vitro dimerization results do not strictly correlate with in vivo infectivity, possibly due to additional RNA interactions that maintain the dimers in cells. UV crosslinking-coupled SHAPE (XL-SHAPE) was next used to determine Gag-induced RNA conformational changes, revealing G218 as a critical Gag contact site. Overall, our results suggest that disruption of either of the DIS sequences does not reduce virus replication and reveal specific sites of Gag–RNA interactions.

Original languageEnglish (US)
Article number568
JournalViruses
Volume12
Issue number5
DOIs
StatePublished - May 2020

All Science Journal Classification (ASJC) codes

  • Infectious Diseases
  • Virology

Fingerprint Dive into the research topics of 'Rous sarcoma virus genomic RNA dimerization capability in vitro is not a prerequisite for viral infectivity'. Together they form a unique fingerprint.

  • Cite this

    Liu, S., Maldonado, R. K., Rye-McCurdy, T., Binkley, C., Bah, A., Chen, E. C., Rice, B. L., Parent, L. J., & Musier-Forsyth, K. (2020). Rous sarcoma virus genomic RNA dimerization capability in vitro is not a prerequisite for viral infectivity. Viruses, 12(5), [568]. https://doi.org/10.3390/v12050568